Literature DB >> 19915839

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

Ronald Boellaard1, Mike J O'Doherty, Wolfgang A Weber, Felix M Mottaghy, Markus N Lonsdale, Sigrid G Stroobants, Wim J G Oyen, Joerg Kotzerke, Otto S Hoekstra, Jan Pruim, Paul K Marsden, Klaus Tatsch, Corneline J Hoekstra, Eric P Visser, Bertjan Arends, Fred J Verzijlbergen, Josee M Zijlstra, Emile F I Comans, Adriaan A Lammertsma, Anne M Paans, Antoon T Willemsen, Thomas Beyer, Andreas Bockisch, Cornelia Schaefer-Prokop, Dominique Delbeke, Richard P Baum, Arturo Chiti, Bernd J Krause.   

Abstract

The aim of this guideline is to provide a minimum standard for the acquisition and interpretation of PET and PET/CT scans with [18F]-fluorodeoxyglucose (FDG). This guideline will therefore address general information about[18F]-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) and is provided to help the physician and physicist to assist to carrying out,interpret, and document quantitative FDG PET/CT examinations,but will concentrate on the optimisation of diagnostic quality and quantitative information.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19915839      PMCID： PMC2791475          DOI： 10.1007/s00259-009-1297-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


  37 in total

1.  Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases.

Authors:  Ken-Shwo Dai; Der-Yan Tai; Ping Ho; Chien-Chih Chen; Wen-Chung Peng; Shih-Te Chen; Chun-Chieh Hsu; Yu-Ping Liu; Hsiu-Ching Hsieh; Chin-Chang Yang; Ming-Chuan Tsai; Simon J T Mao
Journal:  Clin Chim Acta       Date:  2004-11       Impact factor: 3.786

2.  Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.

Authors:  Nanda C Krak; R Boellaard; Otto S Hoekstra; Jos W R Twisk; Corneline J Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-15       Impact factor: 9.236

3.  Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.

Authors:  H R Schelbert; C K Hoh; H D Royal; M Brown; M N Dahlbom; F Dehdashti; R L Wahl
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

Review 4.  Monitoring response to treatment in patients utilizing PET.

Authors:  Norbert E Avril; Wolfgang A Weber
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

5.  Measurement of 18F-FDG concentrations in blood samples: comparison of direct calibration and standard solution methods.

Authors:  Henri N J M Greuter; Ronald Boellaard; Arthur van Lingen; Eric J F Franssen; Adriaan A Lammertsma
Journal:  J Nucl Med Technol       Date:  2003-12

6.  Optimization of attenuation correction for positron emission tomography studies of thorax and pelvis using count-based transmission scans.

Authors:  R Boellaard; A van Lingen; S C M van Balen; A A Lammertsma
Journal:  Phys Med Biol       Date:  2004-02-21       Impact factor: 3.609

7.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

Review 8.  The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.

Authors:  E Bastiaannet; H Groen; P L Jager; D C P Cobben; W T A van der Graaf; W Vaalburg; H J Hoekstra
Journal:  Cancer Treat Rev       Date:  2004-02       Impact factor: 12.111

9.  Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

Authors:  V J Lowe; D M DeLong; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

10.  Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002).

Authors:  P Bourguet; M P Blanc-Vincent; A Boneu; L Bosquet; B Chauffert; C Corone; F Courbon; A Devillers; H Foehrenbach; J D Lumbroso; P Mazselin; F Montravers; J L Moretti; J N Talbot
Journal:  Br J Cancer       Date:  2003-08       Impact factor: 7.640
View more
  403 in total

1.  PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.

Authors:  Florian F Behrendt; Yavuz Temur; Frederik A Verburg; Moritz Palmowski; Thomas Krohn; Hubertus Pietsch; Christiane K Kuhl; Felix M Mottaghy
Journal:  Eur Radiol       Date:  2012-06-04       Impact factor: 5.315

2.  [11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.

Authors:  Maria Picchio; Elena Giulia Spinapolice; Federico Fallanca; Cinzia Crivellaro; Giampiero Giovacchini; Luigi Gianolli; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

3.  Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects.

Authors:  E J Somer; L C Pike; P K Marsden
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

4.  Validation of a new protocol for ¹⁸F-FDG infusion using an automatic combined dispenser and injector system.

Authors:  Michela Lecchi; Giovanni Lucignani; Claudio Maioli; Giuseppe Ignelzi; Angelo Del Sole
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-28       Impact factor: 9.236

5.  Variability in PET quantitation within a multicenter consortium.

Authors:  Frederic H Fahey; Paul E Kinahan; Robert K Doot; Mehmet Kocak; Harold Thurston; Tina Young Poussaint
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

6.  Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.

Authors:  An-Na Tong; Shao-Rong Han; Peng Yan; Hai Gong; Hui Zhao; Hui Yao; Yan-Ming Wang
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

7.  Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.

Authors:  Federico Caobelli; Pierpaolo Alongi; Laura Evangelista; Maria Picchio; Giorgio Saladini; Marco Rensi; Onelio Geatti; Angelo Castello; Iashar Laghai; Cristina E Popescu; Carlotta Dolci; Cinzia Crivellaro; Silvia Seghezzi; Margarita Kirienko; Vincenzo De Biasi; Fabrizio Cocciolillo; Natale Quartuccio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-18       Impact factor: 9.236

8.  Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.

Authors:  Robert K Doot; Larry A Pierce; Darrin Byrd; Brian Elston; Keith C Allberg; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

9.  A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Authors:  Robert L Harrison; Brian F Elston; Robert K Doot; Thomas K Lewellen; David A Mankoff; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Dynamic changes of FDG uptake and clearance in normal tissues.

Authors:  Gang Cheng; Abass Alavi; Esther Lim; Thomas J Werner; Catherine V Del Bello; Scott R Akers
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.